Plasma angiotensin II concentrations and the effect of treatment with enalapril in dogs with proteinuria due to renal disease

Veterinary Quarterly

Volumn 19, Issue , 1997, Pages 18-19

  Piek, C J ^a   Meyer, H P ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842867136     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1997.9694785     Document Type: Article

References (12)

1. Anderson S, Meyer TW, Rennke HG, and Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76:612–9.
2. Anderson S, Rennke IIG, and Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000.
3. Essen GG van, Rensma PL, Zeeuw D de, Sluitcr WJ, Scheffer H, Apperloo AJ, and Jong PE dc. Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotcctivc therapy. Lancet 1996; 347:94–5.
4. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, and Schwartz SM. Renal injury from angiotensin U-mediated hypertension. Hypertension 1992; 19:464–74.
5. Kagami S, Border WA, Miller DE. and Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-b expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431–7.
6. Lewis EJ, Hunsickcr LG, Raymond PB, and Rohde RD. The effect of angiotcnsin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993:329:1456–62.
7. Liou HH, Huang TP, and Campese VM. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron 1995; 69:41–8.
8. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ucda N, Kamada T, and Imai E. Association of Angiotensin I-converting enzyme Gene polymorphism with susceptibility to antiproteinuric effect of Angiotensin l-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995; 6:1674–8.
9. Rcmuzzi A, Benigni A, Malanchini B, Bruzzi I, Foglieni C, and Remuzzi G. ACE inhibition prevents renal failure aand death in unincphrcctomized MWF/Ztm rats. Kidney Int 1995; 47:1319–26.
10. Strutz F, and Miiller GA. On the progression of chronic renal disease. Nephron 1995; 69:371–9.
11. Ter Wee P, and Epstein M. Angiotensin-converting enzyme inhibitors and progression of nondiabetic chronic renal disease. Arch Intern Med 1993; 153:1749–59.
12. Yoshida H, Kon V, and Ichikawa I. Polymorphisms of the rcnin-angio-tensin system genes in progressive renal diseases. Kidney Int 1996; 50723–44.